116
Views
10
CrossRef citations to date
0
Altmetric
Articles

Association Between HACE1 Gene Polymorphisms and Wilms' Tumor Risk in a Chinese Population

, , , , , , , , , & ORCID Icon show all
Pages 633-638 | Received 20 Apr 2017, Accepted 27 Oct 2017, Published online: 15 Dec 2017
 

ABSTRACT

Wilms' tumor is one of the most common solid tumors of childhood; however, the genetic basis underlying the majority of cases remains largely unknown. HACE1 is a putative Wilms' tumor susceptibility gene. We investigated the association between five HACE1 gene polymorphisms and Wilms' tumor susceptibility in a Chinese population consisting of 145 patients and 531 controls. We found a significant association between HACE1 rs9404576 polymorphism and decreased Wilms' tumor risk. No significant association was detected for other polymorphisms in the overall analysis. Our results indicated that HACE1 rs9404576 polymorphism may be associated with Wilms' tumor susceptibility in the Chinese population.

Declaration of interest

The authors report no conflicts of interest.

Funding

This study was supported by grants from Pearl River S&T Nova Program of Guangzhou (No: 201710010086), the Science and Technology Planning Project of Guangdong Province (No: 2016A020215009), State Clinical Key Specialty Construction Project (Pediatric Surgery) 2013 (No: GJLCZD1301), and Guangzhou Medical and Health Science and Technology projects in 2013 (No: 20131A011068).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.